πŸ›οΈ Verified NIH Record β€’ Updated 2026-07-07

Prospective Catalystem CT-RSA (NCT07698717)

Multi-center, Non-controlled, Prospective CT-based Radiostereometric Analysis of Catalystem Primary Hip System

🟑 Not Yet Recruiting Observational / Diagnostic βš™οΈ Medical Device Protocol Sponsor: Canadian Radiostereometric Analysis Network

🩺 Plain-English Summary (8th-Grade Level)

Multi-Centre Study in patients undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEMβ„’ Primary Hip System. The primary objective is to establish the mean inferior stem migration (subsidence) of the CATALYSTEMβ„’ stem using CT-RSA over the first two postoperative years.

Who can join: Review the eligibility criteria below.

Location: Orthopaedic Innovation Centre β€” Winnipeg, Manitoba

Age range: 21 Years

πŸ§ͺ Interventions in This Study

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (1 Sites)

  • Orthopaedic Innovation Centre β€” Winnipeg, Manitoba

πŸ“ž Contact the Study Coordinator

Phone: (204) 926-1231

Email: stran@orthoinno.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—